MRC Biotech has licensed or assigned technologies from the University of New South Wales, through their commercialisation office NewSouth Innovations.  We continue to work closely with the University as all pre-clinical work is undertaken at the University’s St. George Cancer Research Laboratory, under the direction of Professor David Morris and Dr Mohammad Pourgholami.  Both scientists have been working on the underlying technology within MRC Biotech for many years and are co-inventors on our MRC202 and MRC304 patents.  Professor David Morris is the sole inventor on our Vitamin D3 patents.